Lam Research Forecast, price target & analysts
Why the stock moved Beta
Lam Research Target price 2026 - Analyst rating & recommendation
Lam Research Classifications & Recommendation
Lam Research Price Target
| Target Price | $369.75 |
| Price | $288.11 |
| Potential | 28.34% |
| Number of Estimates | 35 |
| 35 Analysts have issued a price target Lam Research 2027 . The average Lam Research target price is $369.75. This is 28.34% higher than the current stock price. The highest price target is $525.00 82.22% , the lowest is $215.13 25.33% . | |
| A rating was issued by 41 analysts: 35 Analysts recommend Lam Research to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Lam Research stock has an average upside potential 2027 of 28.34% . Most analysts recommend the Lam Research stock at Purchase. |
Sales and Margin forecast 2027, 2028 to 2031
38 Analysts have issued a sales forecast Lam Research 2027 . The average Lam Research sales estimate is
This results in the following potential growth metrics:
25 Analysts have issued an Lam Research EBITDA forecast 2027. The average Lam Research EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
39 Lam Research Analysts have issued a net profit forecast 2027. The average Lam Research net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2031
39 Analysts have issued a Lam Research forecast for earnings per share. The average Lam Research EPS is
This results in the following potential growth metrics and future valuations:
Current Lam Research Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Buy
➜
Buy
|
Unchanged | Sep 01 2026 |
| Mizuho |
Outperform
➜
Outperform
|
Unchanged | Aug 25 2026 |
| Jefferies |
Buy
➜
Buy
|
Unchanged | Jul 30 2026 |
| Needham |
Buy
➜
Buy
|
Unchanged | Jul 30 2026 |
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Jul 30 2026 |
| B. Riley Securities |
Buy
➜
Buy
|
Unchanged | Jul 30 2026 |
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Jul 30 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
UBS:
Buy
➜
Buy
|
Sep 01 2026 |
|
Unchanged
Mizuho:
Outperform
➜
Outperform
|
Aug 25 2026 |
|
Unchanged
Jefferies:
Buy
➜
Buy
|
Jul 30 2026 |
|
Unchanged
Needham:
Buy
➜
Buy
|
Jul 30 2026 |
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Jul 30 2026 |
|
Unchanged
B. Riley Securities:
Buy
➜
Buy
|
Jul 30 2026 |
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Jul 30 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
